CIK 0001275187 · Accelerated filer
ANGIODYNAMICS INC
Sign in to watch- Ticker
- ANGO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113146460
- Phone
- 5187981215
- Business address
- 14 PLAZA DRIVE, LATHAM, NY, 12110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $310,688
- in 1 filing
Net −$310,688. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-14 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −571 | $26.43 | $15K | 23,153 |
| 2021-07-14 | Clemmer James C President and CEO | Shares withheld for taxes | −4,622 | $26.43 | $122K | 338,697 |
| 2021-04-15 | Trowbridge Stephen A EVP and CFO | Option exercise | +13,625 | $14.07 | $192K | 73,371 |
| 2021-04-15 | Trowbridge Stephen A EVP and CFO | Shares withheld for taxes | −10,080 | $24.21 | $244K | 63,291 |
| 2021-04-15 | Trowbridge Stephen A EVP and CFO | Option exercise · Non-Qualified Stock Option (right to buy) | −13,625 | 0 | ||
| 2021-04-14 | Helsel Dave SVP Global Operations and R&D | Sale | −3,500 | $23.93 | $84K | 19,115 |
| 2021-04-01 | DONNELLY HOWARD W Director | Option exercise | +5,726 | $14.64 | $84K | 96,595 |
| 2021-04-01 | DONNELLY HOWARD W Director | Shares withheld for taxes | −3,621 | $23.15 | $84K | 92,974 |
| 2021-04-01 | DONNELLY HOWARD W Director | Option exercise · Non-Qualified Stock Option (right to buy) | −5,726 | 0 | ||
| 2021-02-03 | Trowbridge Stephen A EVP and CFO | Shares withheld for taxes | −527 | $19.24 | $10K | 59,746 |
| 2021-02-01 | ROSENZWEIG RICHARD C SVP and General Counsel | Grant or award | +11,000 | 11,000 | ||
| 2021-02-01 | ROSENZWEIG RICHARD C SVP and General Counsel | Grant or award · Non-Qualified Stock Option (right to buy) | +62,000 | 62,000 | ||
| 2021-01-20 | JOHNSON WESLEY Director | Sale | −6,500 | $18.53 | $120K | 77,911 |
| 2020-12-18 | Helsel Dave SVP Global Operations and R&D | Shares withheld for taxes | −733 | $14.29 | $10K | 22,615 |
| 2020-10-31 | Centea Scott SVP/GM, VIT | Shares withheld for taxes | −849 | $10.62 | $9K | 45,004 |
| 2020-08-11 | Trowbridge Stephen A EVP and CFO | Purchase | +1,013 | $9.38 | $10K | 60,273 |
| 2020-07-31 | Clemmer James C President and CEO | Purchase | +40,000 | $8.26 | $330K | 343,319 |
| 2020-07-27 | Trowbridge Stephen A EVP and CFO | Shares withheld for taxes | −292 | $8.80 | $3K | 59,260 |
| 2020-07-27 | Clemmer James C President and CEO | Shares withheld for taxes | −1,799 | $8.80 | $16K | 303,319 |
| 2020-07-27 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −259 | $8.80 | $2K | 23,724 |
Page 21 of 30 · 589 trades